Monocytes are a critical component of the cellular innate immune system, and can be subdivided into classical, intermediate and non-classical subsets on the basis of surface CD14 and CD16 expression. Classical monocytes play the canonical role of phagocytosis, and account for the majority of circulating cells. Intermediate and non-classical cells are known to exhibit varying levels of phagocytosis and cytokine secretion, and are differentially expanded in certain pathological states. Characterisation of cell surface proteins expressed by each subset is informative not only to improve understanding of phenotype, but may also provide biological insights into function. Here we use highly multiplexed Tandem-Mass-Tag (TMT)based mass spectrometry with selective cell surface biotinylation to characterise the classical monocyte surface proteome, then interrogate the phenotypic differences between each monocyte subset to identify novel protein markers.
Introduction
Monocytes play critical roles in the response to infection and inflammation and antigen presentation. Key effector functions are mediated by differentiated cells, including macrophages and myeloid dendritic cells. Monocytes can be divided into subsets based on the presence of the cell surface lipopolysaccharide (LPS) co-receptor CD14, and Fc-Gamma
Receptor III (CD16). CD14++ CD16-classical monocytes account for ~85% of circulating monocytes; intermediate cells (CD14++ CD16+) for ~5% and non-classical cells (CD14+ CD16++) for ~10% of circulating monocytes 1, 2 . It has become increasingly well established that each subset plays divergent roles in different diseases, as well as differing in the ability to secrete cytokines and respond to pathogen associated molecular patterns (PAMPs).
Classical monocytes are phagocytic and readily secrete inflammatory cytokines. Conversely, the CD16 positive non-classical cells are poorly phagocytic and are suggested to secrete TNFα in response to some stimuli, but less of other pro-inflammatory molecules 2, 3, 4 . Intermediate monocytes are increased in diseases such as severe asthma, rheumatoid arthritis and sarcoidosis, and there is some evidence for expansion of classical monocytes in atherosclerosis [5] [6] [7] [8] . It is still unclear whether intermediate monocytes represent a truly distinct monocyte subset, or merely a transitional stage between classical and non-classical cells 9 .
Cells of the innate and adaptive immune systems can be categorised on the basis of microscopic appearance and expression of plasma membrane (PM) proteins, enabling separation by fluorescence activated cell sorting (FACS). As such, systematic evaluation of the entire cell surface proteome expressed by a given immune cell population is a powerful tool to characterise cellular function and distinguish cell types. Previous studies of monocytes subsets have exclusively examined transcriptional differences and offer varying depths of information about subset markers, suitability of individual proteins for discriminating subsets by cell surface flow cytometry and the importance of each protein in different pathological states 2, 8, 10, 11 . Usage of multiple complementary grouping systems has the benefit of improving cellular assignment, in addition to enabling discovery of new cellular phenotypes 8, 12 .
Here we use selective surface protein biotinylation with multiplexed tandem mass tag (TMT)based mass spectrometry to directly measure the first comprehensive surface proteome of primary human classical monocytes from three donors. 373 classical monocyte cell surface proteins were quantified, and the relative abundance of each protein estimated. The surface proteome of classical, intermediate and non-classical cells was then compared to identify unique markers of each subset. Amongst these, Integrin alpha subunit 5 (ITGA5), complement receptor 1 (CR1/CD35) and Leukotriene B4 receptor (LTB4R) were defined as markers of classical monocytes, and Sialic Acid Binding Ig Like Lectin 10 (SIGLEC10) as a marker of nonclassical cells.
RESULTS

Establishing a definitive classical monocyte surface proteome
To establish a surface proteome map, monocytes were enriched from three independent peripheral blood mononuclear cell (PBMC) donations from healthy donors by negative selection with magnetic beads. Classical monocytes were then enriched by FACS after staining for CD86, CD14 and CD16 ( Supplementary Fig. S1 ). Selective surface oxidation and aminoxybiotinylation was used to label cell surface glycoproteins, which were enriched from cellular lysates using streptavidin beads, then digested into peptides using trypsin. Peptides were labelled with TMT, samples combined and then quantified by MS3 mass spectrometry 13, 14 (Fig. 1a) .
437 proteins were identified from the three samples, of which 373 were annotated 'cell surface', 'plasma membrane', 'extracellular' or with a short Gene Ontology term as previously described 13, 14 ( Supplementary table S1d ). Application of DAVID software to determine which pathways were enriched amongst these proteins indicated the presence of multiple components of integrin complexes and cell-cell junctions in addition to 'glycosylation' and 'disulphide bond', serving to validate our selective labelling approach (Fig. 1b ). 
Figure 1
Quantification of the classical monocyte cell surface proteome
We used a method derived from identity based absolute quantitation (iBAQ) to compare the contribution of each protein to the classical monocyte cell surface proteome. The summed MS1 maximum precursor intensity for each protein across all matching peptides was divided by the theoretical number of tryptic peptides 7-30 amino acids in length. Values thus effectively represent an average across three donors, offering the opportunity to provide precise information on the overall abundance of each PM protein, independent of individual genetic variation. Abundance values ranging over approximately five orders of magnitude were found, with 21 proteins collectively contributing 68.6% of the cell surface proteome, whilst individually contributing >1% (Fig. 2) . The five most abundant surface proteins, CD44, SPN, ICAM3, ITGB2 and BSG accounted for ~25% of the surface proteome, with CD14 representing ~3.5% (Fig. 2) . The summed abundance of class I Major Histocompatability antigen (MHC) accounted for 2.0% of surface proteins, and class II MHC 0.7%. By using multiplexed TMT-based proteomics, this study offered the opportunity to directly measure the variability in expression of whole surface proteomes across different donors. 76.1% of proteins exhibited a <30% coefficient of variation (%CV). There was also no systematic inverse relationship between abundance and variability, i.e. less abundant proteins were not systematically more poorly quantified ( Supplementary Fig. S2 ). The summed abundances of all MHC class I molecules and MHC class II molecules were considered in order to account for different alleles expressed by individual donors.
Figure 2
Comparison of the cell surface proteome of different monocyte subsets
Although the majority of circulating monocytes belong to the classical subset, the nonclassical and intermediate subsets play an increasingly appreciated role in different diseases.
Selective cell surface biotinylation with MS3-based mass spectrometry was used to investigate phenotypic differences between each subset in biological triplicate. From this analysis, 313 proteins annotated 'cell surface', 'plasma membrane', 'extracellular' or with a short GO term were quantified (Supplementary table S1e). Principle component analysis (PCA) suggested that classical monocytes had a more distinct cell surface proteome in comparison to non-classical and intermediate cells ( Fig. 3a) . K-means clustering with 1-20 classes suggested there were at least eight distinct patterns of protein expression between monocyte subsets ( Fig. 3b-c 
Comparison to RNA microarray data
Previous analyses of monocyte subsets have mostly been performed at the level of RNA expression 2, 8, 10, 11 . Hierarchical clustering was used to assess the complementarity between one of the most comprehensive previous transcriptomic studies 2 and this proteomic analysis.
For each protein, each data type was normalised to a maximum of 1 after averaging signal:noise (proteomics) or median fluorescent intensity values (microarray) across donors ( Supplementary Fig. S3 ). RNA and protein data for the classical subset clustered separately from non-classical and intermediate subsets. However, intermediate protein-RNA did not neatly separate from the non-classical pair suggesting that these cells may be more phenotypically similar to one another than classical monocytes, in keeping with the PCA ( Fig. S4 ).
Validation of cell surface subset markers
Flow cytometry was used to validate a group of monocyte subset markers identified by proteomics, using independent samples from three different healthy donors of European heritage. SIGLEC10 validated as a marker most abundantly expressed by non-classical monocytes ( Fig. 4a-b) 2 . ITGA5, CR1 and LTB4R also validated as markers of classical monocytes identified by proteomic data (Fig. 4a-b For both types of analyses, data were normalised to a maximum of one then averaged across the three replicates. Data are shown as mean +/-SEM. For proteomic data, a Benjamini-Hochberg-corrected two-tailed t-test was used to estimate p-values. For flow cytometry data, a two-tailed t-test was used to estimate p-values. *p< 0.05; **p<0.005. b) Representative contour plots from a single donor of flow cytometry data for each illustrated marker coloured by cell subset. FSC-A (Forward Scatter Area.) was used as an intrinsic description of cell size (which would not be expected to change between subsets) to separate the points on a second axis. This representation was advantageous compared to the alternative of histograms as it more clearly visually represents the distribution of data points with less confounding by absolute cell number. The relative proportion of each monocyte subset is different in peripheral blood, with classical monocytes predominating.
DISCUSSION
Here we use cell surface specific protein enrichment in combination with isobaric tagging and MS3 mass spectrometry to define at high resolution the cell surface proteomes of monocyte subsets. This has not only identified novel markers of each subset but also provided a valuable resource for the future study of these crucial immune cells. This represents the first cell surface proteomic study in primary monocyte subsets. Up to now, other cell surface proteomic analyses in primary cells have been limited to CD4+ T-cells 16 , erythrocytes 17, 18 , NK cells, adipocytes and a subset of tumour cells 19 . We quantify 373 cell surface proteins from classical monocytes, and further quantify 313 proteins across all monocyte subsets. Based on our data we predict that the majority of the classical monocyte cell surface proteome is composed of a relatively small number of different proteins. Limitations to this study include the number of donors. To ensure all samples could be directly compared in a single TMT analysis, three subpopulations of monocytes from three donors were analysed, since only 10 different TMT tags were available. Furthermore, demographic information for each donor was not available, meaning that characteristics such as gender might bias our analysis.
Nevertheless, we believe this study provides important cell surface protein level data to complement the rapidly growing array of RNA studies of different leucocyte subsets.
Here we show CR1, LTB4R and ITGA5 are markers of classical monocytes, and SIGLEC10 is a marker of non-classical monocytes. CR1 (Complement Receptor type 1 / CD35), acts as a cell surface receptor for particles opsonised by complement, facilitating their phagocytosis 20 . The specific elevation of CR1 on classical monocytes is consistent with their predominant phagocytic role.
LTB4R (also known as BLT1) is a cell surface G-protein coupled receptor for the proinflammatory leukotriene B4 (LTB4). It was originally functionally identified by subtractive cloning of cDNAs from cells differentially able to bind LTB4, and was observed to enable chemotactic response to LTB4 even in non-specialised non-immune cells 21 . Furthermore, LTB4R deletion has previously been reported to confer resistance to histopathological changes in response to a rodent model of inflammatory arthritis 22 . Given the previous link of certain monocytic subsets to inflammatory arthrititis 6 it may be of interest to reassess the role of LTB4R positive classical monocytes in this pathology.
Integrin Alpha 5 (ITGA5, CD49e), is one of 18 mammalian alpha integrin chains which form cell surface heterodimers with integrin beta subunits 23 . Integrins are classically involved in extracellular adhesion and invasion, and also play roles in bidirectional transmembrane signalling 24 . SIGLEC10 was initially identified as a sialic acid binding protein expressed across a variety of tissues, but found at a particularly high level in organs rich in haematopoietic cells, and is notably expressed on dendritic cells and CD16+ cells 10, 25, 26 . SIGLEC10 acts as a ligand for vascular adhesion protein 1 (VAP1), and plays a role in lymphocyte adhesion to endothelial surfaces 27 . The differential expression of both of these adhesion molecules between classical and non-classical monocytes may thus contribute to independent mobility or effector function, although future studies will be required to assess the biological function of SIGLEC10 on these cell types.
The abundance of SLC6A6 was elevated at the surface of intermediate monocytes. SLC6A6 is a known taurine and beta-alanine transporter with proposed roles in regulation of apoptosis 28, 29 . Further studies will be required to investigate whether this molecule modulates the survival of intermediate monocytes relative to the other subsets. Similarly, our data suggested that TSPAN14 was relatively enriched on non-classical monocytes. TSPAN14 is a member of a family of tetraspanins known to regulate the subcellular localisation of metalloproteinase ADAM10 30 ; this might in part explain differences in ADAM10 expression we observed between different monocyte subsets.
To determine if any particular functional class of protein was enriched in each monocyte subpopulation, we used DAVID analysis to compare proteins enriched in different subsets from our k-means analysis (Fig. 3c) . Unfortunately, at least partly due to the relatively small background of proteins (313 proteins in total), only a single term was significantly enriched (p<0.05) within these groupings. It is therefore difficult to make confident, global statements Supplementary table S3 ). We speculate that the divergent role of the monocyte subsets in varying disease states could partially be explained by their differential interactions consequent on differential expression of these molecules. For example, CD33 polymorphisms have been implicated in genetic susceptibility to Alzheimer's disease, with risk alleles correlating with increased CD33 expression and altered phagocytic activity 31 .
As standard in our cell surface proteomic analyses we included proteins annotated with the Gene Ontology Cellular Compartment terms 'plasma membrane' (267/313 proteins), 'extracellular' (110/313 proteins), 'cell surface' (95/313 proteins) and a short term that indicates that the protein is membrane-integral, however that the subcellular localisation is presently unknown (7/313 proteins) (shown in Supplementary Table 1E ) 13, 32 . This strategy facilitates a comprehensive coverage of the cell surface proteome. From the 313 proteins, 31
were annotated 'extracellular' but not 'plasma membrane' or 'cell surface'. These included Lysozyme and Haptoglobin. Certain extracellular proteins can clearly bind to proteins or receptors at the plasma membrane. For example, Haptoglobin is known to bind CD163 33 , which we also detected in our analysis.
Although two previous reports have quantified the whole cell proteome of monocyte subsets 34, 35 , ours represents the first selective study of the cell surface proteome of these primary cell types. Furthermore, one of the previous studies 34 pooled non-classical and intermediate phenotype cells prior to analysis, and the other did not examine intermediate phenotype cells 35 . We compared our data to both studies. As might be anticipated due to the low abundance and hydrophobic nature of cell surface proteins, each prior study only identified a fraction of the cell surface proteins found by selective surface biotinylation.
Furthermore, for each subset of proteins previously identified as differentially expressed, there was generally poor correspondence to our data. There are a number of possible explanations for this finding, particularly including a small sample size of differentially expressed proteins that were also quantified in our study in each case. Additionally, correspondence between cell surface and whole-cell protein abundances can in any case be poor, and there may have been some confounding in one of the prior studies from isolation and measurement of protein samples in five different locations, using four different types of mass spectrometer 35 . Neither prior study examined intermediate-phenotype cells. We believe this shows the clear benefits of selective interrogation of the cell surface proteome, in a single multiplexed experiment that can make precise quantitative comparisons.
Although the monocyte subsets can be delineated using CD14/CD16 expression, use of further markers in parallel could aid distinction of subgroups which may appear as a near continuum if viewed in only two dimensions 12 . It has previously been suggested that the intermediate monocyte subset may be a transitional state between the two larger circulating monocyte populations, and the classical subset are more distinct from intermediate and nonclassical cells than the latter two populations are from one another. Our data support this second observation. However, we also identified proteins that are uniquely up-or downregulated in intermediate cells, arguing against the hypothesis that these cells may be purely transitional. Future work will be required to determine which combinations of markers can be used to definitively separate individual subsets, and will expand recent single cell transcriptomic data which has suggested that intermediate monocytes are more heterogenous than previously anticipated 9, 36 . Additionally, further studies will also be required to examine the monocyte cell surface from individuals with diseases including asthma, rheumatoid arthritis and sarcoidosis to determine whether subpopulations exhibit phenotypic differences in these conditions. We thus provide an orthogonal analysis of monocyte subgroups to complement previous transcriptomic studies which will facilitate many future studies of monocytes. This valuable resource may also be useful to assist elucidation of the true nature of intermediate monocytes.
MATERIALS AND METHODS
Monocyte isolation
For proteomic studies, leukocyte enriched blood samples were obtained from healthy UK- 
Plasma membrane profiling
Plasma membrane profiling was performed broadly as previously described 13 , with the following modifications. The total number of monocytes biotinylated was dependent on the yield from enrichment procedures detailed above, typically in the range of 10 5 -10 6 
Offline SCX fractionation
Offline fractionation was performed as previously described 14, 37 with the following modifications. 10 mg of PolySulfethyl A bulk material (Nest Group Inc) was loaded on to a fritted 200 l tip in 100% Methanol using a vacuum manifold. SCX material was conditioned slowly with 1ml SCX buffer A (7 mM KH2PO4, pH 2.65, 30% Acetonitrile), then 0.5 ml SCX buffer B (7 mM KH2PO4, pH 2.65, 350mM KCl, 30% Acetonitrile) then 2ml SCX buffer A. Dried peptides were resuspended in 500 l SCX buffer A and added to the tip at a flow rate of ~150 l/min, followed by a 150 l wash with SCX buffer A. Fractions were eluted in 150 l buffer at increasing K+ concentrations (10, 25, 40, 60, 90, 150 mM KCl), vacuum-centrifuged to near dryness then desalted using StageTips.
LC-MS3
LC-MS3 was performed with modifications as previously described 38, 39 . Mass spectrometry data was acquired using an Orbitrap Lumos (Thermo Fisher Scientific, San Jose, CA). An Ultimate 3000 RSLC nano UHPLC equipped with a 300 µm ID x 5 mm Acclaim PepMap µ-Precolumn (Thermo Fisher Scientific) and a 75 µm ID x 50 cm 2.1 µm particle Acclaim PepMap RSLC analytical column was used. An unfractionated singleshot was analysed initially to ensure similar peptide loading across each TMT channel, thus avoiding the need for excessive electronic normalization. As all normalisation factors were >0.33 and <3.0, data for each singleshot experiment was analysed with data for the corresponding fractions to increase the overall number of peptides quantified. For monocyte subset analysis, 2µl of fractionated peptide was initially analysed by mass spectrometry, followed by the remainder of the sample having observed satisfactory chromatography.
For LC/MS3, loading solvent was 0.1% trifluoroacetic acid (TFA), analytical solvent A: 0.1% FA and B: 80% acetonitrile + 0.1% FA. All separations were carried out at 55°C. Samples were loaded at 10 µl/minute for 5 minutes in loading solvent before beginning the analytical gradient. The following gradient was used: 3-7% B over 4 minutes, 7-37% B over 58 minutes, 37-95% B over 4 minutes followed by a 2 minute wash at 95% B and equilibration at 3% B for 15 minutes. Each analysis used a MultiNotch MS3-based TMT method 40, 41 
Data analysis
Data analysis was performed with modifications as previously described 18, 38 . In the following description, we list the first report in the literature for each relevant algorithm.
Mass spectra were processed using a Sequest-based software pipeline for quantitative proteomics, "MassPike", through a collaborative arrangement with Professor Steve Gygi's laboratory at Harvard Medical School. MS spectra were converted to mzXML using an extractor built upon Thermo Fisher's RAW File Reader library (version 4.0.26). In this extractor, the standard mzXML format has been augmented with additional custom fields that are specific to ion trap and Orbitrap mass spectrometry and essential for TMT quantitation. Searches were performed using a 20 ppm precursor ion tolerance 42 . Fragment ion tolerance was set to 1 Da. TMT tags on lysine residues and peptide N termini (229.162932 Da) and carbamidomethylation of cysteine residues (57.02146 Da) were set as static modifications, while oxidation of methionine residues (15.99492 Da) was set as a variable modification.
To control the fraction of erroneous protein identifications, a target-decoy strategy was employed 43, 44 . Peptide spectral matches (PSMs) were filtered to an initial peptide-level false discovery rate (FDR) of 1% with subsequent filtering to attain a final protein-level FDR of 1% 45, 46 . PSM filtering was performed using a linear discriminant analysis, as described previously 47 . This distinguishes correct from incorrect peptide IDs in a manner analogous to the widely used Percolator algorithm 48 , though employing a distinct machine learning algorithm. The following parameters were considered: XCorr (minimum 1), ΔCn, missed cleavages, peptide length, charge state, and precursor mass accuracy. Protein assembly was guided by principles of parsimony to produce the smallest set of proteins necessary to account for all observed peptides 47 .
Proteins were quantified by summing TMT reporter ion counts across all matching peptidespectral matches using "MassPike", as described previously 40, 41 . Briefly, a 0.003 Th window around the theoretical m/z of each reporter ion (126, 127n, 127c, 128n, 128c, 129n, 129c, 130n, 130c) was scanned for ions, and the maximum intensity nearest to the theoretical m/z was used. The primary determinant of quantitation quality is the number of TMT reporter ions detected in each MS3 spectrum, which is directly proportional to the signal-to-noise (S:N) ratio observed for each ion 49 . Conservatively, every individual peptide used for quantitation was required to contribute sufficient TMT reporter ions so that each on its own could be expected to provide a representative picture of relative protein abundance 40 . An isolation specificity filter was additionally employed to minimise peptide co-isolation 50 . Peptidespectral matches with poor quality MS3 spectra (more than 9 TMT channels missing and/or a combined S:N ratio of less than 135 (9-plex, monocyte subsets) or 45 (3- Proteins were filtered to include those most likely to be present at the cell surface with high confidence. These contained proteins with the Gene Ontology (GO) terms of 'plasma membrane' (PM), 'cell surface' (CS), 'extracellular' (XC) or with a short 4-or 5-part GO cellular compartment term that included 'integral to membrane', but with no subcellular assignment 13 (ShG).
To estimate the relative abundance of each protein, a method based on iBAQ was employed.
The summed MS1 maximum precursor intensity for each protein across all matching peptides was calculated. Each value was divided by the number of theoretically observable tryptic Supplementary Fig. S1 . For Fig. 4 , monocytes were gated into subsets: CD14++, CD16-(Classical), CD14++, CD16+ (Intermediate), CD14+, CD16++ (Non-classical). MFI values for each subset were normalised to a maximum of 1 prior to averaging and calculation or the standard deviation and standard error of the mean.
Experimental design
For each proteomic analysis (classical monocyte or subset analysis) three independent samples were obtained and prepared separately prior to simultaneous isobaric tag labelling and further analysis. Triplicate analysis was chosen to take advantage of the capability to study up to 10 samples simultaneously using tandem mass tags. As such, three complete sets of three subsets were chosen. Validation studies using flow cytometry were performed in biological triplicate from three independent donors as described above. Flow cytometry fluorophore staining was performed with singly stained and unstained control populations in addition to the test samples. For proteomic data, a Benjamini-Hochberg-corrected two-tailed t-test was used to estimate p-values. For flow cytometry data, a two-tailed t-test was used to estimate p-values based on an observed near-normal distribution of signal within subgroups.
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